Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Multicenter Lymphangioleiomyomatosis Long Term Sirolimus Trial
jRCT1091220037Unknown
- Sponsor
- Koh Nakata, MD, Ph.D
- Start
- Mar 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of sirolimus in lymphangioleiomyomatosis (LAM), sponsored by Koh Nakata, MD, Ph.D. Primary endpoint: All adverse events. Status: unknown.
02
Drugs
sirolimus
03
Conditions
lymphangioleiomyomatosis (LAM)
Beyond the preview
Go deeper on jRCT1091220037.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1091220037.